BioInformant

Your Global Leader in Stem Cell Market Research

Home » viacord » Page 2

Why I Respectfully Disagree with Other Market Intelligence Reports about Cord Blood Banking

By

Recently, I’ve seen posts on LinkedIn and the web for a cord blood market report titled “Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 – 2020.”

I rarely reflect on products by other companies, but this report is disturbing in that it is painfully inaccurate.

As global business expert Joe Polish likes to say, “The most expensive information is bad information,” and this is a case of that situation.

In the Executive Summary, a highlight of the main findings for this report, Allied Market Research states that the “Cord blood market is expected to grow at 33.5% CAGR from 2012-2020.”
[Read more…]

3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord

By

Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]

3 Eerie Similarities between the Acquisition of Cord Blood Registry® and ViaCord  

By

Cord Blood Registry® recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals. While the announcement was new, there were aspects of the deal that seemed eerily familiar.

CBR® Acquired by AMAG Pharma for Same Multiple on Revenue as PerkinElmer Paid for ViaCord

In particular, three aspects were strangely reminiscent of the deal in which PerkinElmer acquired the cord blood bank ViaCord in 2007.
[Read more…]

BioInformant's World-Class Clients